Pharmacy Times January 23, 2025
Key Takeaways
- The End Drug Shortages Act seeks to improve communication among stakeholders to address drug shortages, requiring manufacturers to notify the FDA of demand surges.
- Ongoing debates about GLP-1 compounding involve safety concerns, with manufacturers opposing compounded versions due to impurity and stability issues.
- HHS’s final rule penalizes healthcare providers for information blocking, aligning with the 21st Century Cures Act to enhance health information interoperability.
Lawmakers Introduce Act to Reduce Frequency, Severity of Drug Shortages
A bipartisan group of federal lawmakers recently introduced the End Drug Shortages Act, designed to reduce the frequency and severity of drug shortages in the United States.
The bill focuses on improving communication among drug manufacturers, the FDA, and pharmacies, mandating that...
Today's Sponsors
Today's Sponsor